Revcovi Intramuscular Injection 2.4mg, containing Elapegademase (genetically recombined), is manufactured by Teijin Pharma. This injectable drug, with YJ code 3959421A1023 and standard 2.4mg 1.5mL x 1 bottle, is an enzyme replacement therapy for adenosine deaminase severe combined immune deficiency (ADA-SCID).
Revcovi Intramuscular Injection 2.4mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).